Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Senju Pharmaceutical Co. Ltd. et al v. Apotex Inc. et al
Case Number:
1:11-cv-01171
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
September 18, 2012
Apotex Defeats Allergan's New Suit Over Pinkeye Patent
Allergan Inc. and two Japanese pharmaceutical companies on Monday failed in their renewed efforts to target Apotex Inc. for infringement of a patent used in Allergan's pinkeye treatment Zymar after a Delaware federal judge said a re-examination of the patent couldn't breathe life into the previously resolved dispute.
-
November 29, 2011
Allergan Sues Apotex Again Over Generic Pinkeye Drug
Allergan Inc. and two Japanese pharmaceutical companies sued generics maker Apotex Inc. again in Delaware on Monday, alleging it has infringed a recently re-examined patent in seeking approval for a generic version of pinkeye treatment Zymar.